FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Accord Healthcare Inc.)

View source ↗

Summary

FDA approved Accord Healthcare Inc.'s supplemental application for Montelukast Sodium (ANDA 202717). This action confirms approval of a supplemental change to t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Exercise-induced Bronchoconstriction
• Perennial Allergic Rhinitis
• Seasonal Allergic Rhinitis

Drugs mentioned

• Montelukast Sodium (Montelukast Sodium)

Snippet

SUPPL AP for MONTELUKAST SODIUM (MONTELUKAST SODIUM)